Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
GLOBETECH PUBLISHING LLC

Antiparalytic Nasal Spray Treats Venomous Snakebites

By HospiMedica International staff writers
Posted on 19 Aug 2013
Topical administration of antiparalytics using a nasal spray could dramatically reduce the number of global fatalities from venomous snakebites.

Researchers at The California Academy of Sciences (CAS; San Francisco, USA) and the University of California, San Francisco (UCSF; USA) have developed an inexpensive, heat-stable, needle-free device that delivers aerosolized neostigmine to reverse paralysis. Since anticholinesterases are used as reversal agents for nondepolarizing curare-derived neuromuscular blocking agents, and are recommended in virtually all cases of neurotoxic snake envenomation, the researchers hypothesized that a topically applied anticholinesterase might also have utility in the early treatment of snakebite.

The researchers then used a continuous infusion of mivacurium—a short-duration nondepolarizing neuromuscular blocking agent—to induce neuromuscular blockade in a volunteer, successfully mimicking important elements of paralysis from snakebite neurotoxicity, including progressive bulbar deficits and neck and respiratory muscle weakness. A subsequent single application of atomized 6% neostigmine quickly improved the clinical measures of neuromuscular blockade. The study was published early online on July 24, 2013, in Clinical Case Reports.

“In addition to being an occupational hazard for field scientists, snakebite is a leading cause of accidental death in the developing world, especially among otherwise healthy young people,” said lead author Matt Lewin, PhD, director of the center for exploration and travel health at the CAS. “We are trying to change the way people think about this ancient scourge and persistent modern tragedy by developing an inexpensive, heat stable, easy-to-use treatment that will at least buy people enough time to get to the hospital for further treatment.”

Snakebite causes numerous fatalities, comparable to that of AIDS in some developing countries. Predominantly killing young and otherwise healthy individuals, the neurotoxins paralyze victims, resulting in death by respiratory failure. There is currently little funding to devise new approaches to address this problem, with more than 75% of patients who die from snakebite not surviving to receive treatment.

Related Links:

California Academy of Sciences
University of California, San Francisco



Inditherm
Harloff
JD Honigberg International

Channels

Surgical Techniques

view channel
Image: The Intact Tissue Excision System (Photo courtesy of Intact Medical).

Minimally Invasive System Removes Intact Breast Lesions

Physicians can now excise breast lesions in their entirety, thus preserving their architectural integrity for diagnostic assessment. The Intact Tissue Excision System surrounds and excises an entire... Read more

Women's Health

view channel
Image: The Bloom Ring fertility app monitoring core temperature (Photo courtesy of Prima-Temp).

Subtle Temperature Sensor Heightens Fertility Awareness

A new self-inserted core temperature sensor helps women detect when a fertility “window of opportunity” opens. The Bloom Ring is a core body temperature fertility sensor that is inserted by the user... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Hospital News

view channel
Image: The new Parkland Memorial Hospital (Photo courtesy of Parkland Memorial Hospital).

New Parkland Memorial Hospital Nears Completion

At nearly twice the size of the current hospital, the new Parkland Memorial Hospital (Dallas, TX, USA) will be one of the first “digital hospitals” in the United States. The new hospital, built at... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.